Pfizer and BioNTech Received U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
On Aug. 22, 2024, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had approved…
Biotechnology | CDC | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
CDC reported COVID-19 at highest level in two years
On Aug. 16, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that COVID-19 infections are…
City birds found to be carriers of antimicrobial resistant bacteria
on Aug. 14, 2024, research led by scientists at the Ineos Oxford Institute for antimicrobial research at Oxford…
WHO/Europe study confirmed lifesaving impact of vaccines against COVID-19 Summer Wave
On Aug. 8, the World Health Organization (WHO) announced results of a study that showed the introduction of…
University of Houston Researchers Created New Treatment and Vaccine for Flu and Various Coronaviruses
On Aug. 6, 2024, a team of researchers, led by the University of Houston, announced they had discovered…
Biotechnology | COVID-19 | Influenza | Life Science News | Plague | Vaccine | WHO
CEPI and WHO urge broader research strategy for countries to prepare for the next pandemic
On Aug. 1, 2024, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO) called…
Paxlovid led to better outcomes in hospitalized COVID cohort than Veklury or both drugs
On Jul. 24, 2024, the University of Hong Kong released a study that showed hospitalized COVID-19 patients treated…
Biotechnology | CDC | COVID-19 | Influenza | Life Science News | Vaccine
CDC Recommended Updated 2024-2025 COVID-19 and Flu Vaccines for Fall/Winter Virus Season
On Jun. 27, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) recommended the updated 2024-2025 COVID-19…
COVID-19 | FDA | Life Science News | Therapeutics | Vaccine
FDA updated COVID-19 Vaccines for Use in the U.S Beginning in Fall 2024
On Jun. 14, 2024, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend…
National Academies announced New Broad Definition of Long COVID
On Jun. 11, 2024, the National Academies of Sciences, Engineering, and Medicine released a new report that stated the…
CSL Seqirus Signed an Agreement with the European Commission to Provide Pre-Pandemic Vaccines to the EU
On Jun. 11, 2024, CSL Seqirus was selected by the Health Emergency Preparedness and Response Authority (HERA), part…
Biotechnology | COVID-19 | FDA | Life Science News | Vaccine
FDA updated COVID-19 Vaccines for Use in the U.S. Beginning in Fall 2024
On June 5, 2024, the U.S. FDA’s Vaccines and Related Biological Products Advisory Committee announced that it had…
COVID-19 eliminated a decade of progress in global level of life expectancy
On May 24, 2024, the World Health Organization (WHO) revealed that the COVID-19 pandemic reversed the trend of…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science History | Life Science News | Vaccine
Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
On May 17, 2024, researchers at Washington University School of Medicine in St. Louis announced a study had…
National Academies reported COVID-19 vaccines don’t cause many potential harms
On May 10, 2024, the National Academies of Sciences, Engineering, and Medicine reported that the COVID-19 vaccines made…
Novavax and Sanofi announced licensing agreement to co-commercialize COVID-19 vaccine and novel COVID-19-influenza combination vaccines
On May 10, 2024, Novavax announced that it had entered into a co-exclusive licensing agreement with Sanofi. The…
COVID vaccines not linked to seizures
On Apr. 30, 2024, a meta-analysis of six randomized controlled trials in JAMA Neurology found no increase in seizures in…
Moderna announced contract with Brazil to supply 12.5 million COVID-19 vaccines as part of national vaccination campaign
On Apr. 22, 2024, Moderna announceda contract with the Ministry of Health in Brazil (Ministerio da Saude) to…
Study suggested staying current with COVID-19 vaccinations helped combat emerging variants
On Apr. 12, 2024, Oregon Health Sciences University (OHSU) announced research that shows using live SARS-CoV-2 virus revealed…
FDA issued EUA for Pemgarda (pemivibart) for pre-exposure prophylaxis of COVID-19 in certain adults and adolescents
On Mar. 22, 2024, the U.S. Food and Drug Administration the FDA issued an emergency use authorization for…
Severe lung infection during COVID-19 caused damage to the heart
On Mar. 20, 2024, a National Institutes of Health-supported study reported that SARS-CoV-2, the virus that causes COVID-19,…
COVID reduced global life expectancy by 1.6 years
On Mar. 14, 2024, the Institute for Health Metrics and Evaluation (IHME) released all-cause mortality, life expectancy, and…
CDC | COVID-19 | Life Science News | Therapeutics | Vaccine
CDC Advisory Committee recommended older adults able to receive additional dose of updated COVID-19 vaccine
On Feb. 28, 2024, the CDC Advisory Committee on Immunization Practices’ (ACIP) announced a recommendation for adults ages…
Biotechnology | CDC | COVID-19 | Vaccine
Novavax’s protein-based non-mRNA COVID-19 vaccine available as additional dose for individuals aged 65 and older
On Feb. 28, 2024, the U.S. Centers for Disease Control and Preventionï¾’s (CDC) Advisory Committee on Immunization Practices…
Biotechnology | COVID-19 | Diagnostics | Life Science News | Non-Profit Research | Therapeutics | Vaccine
First Tissue Bank May Help Solve Mystery of Long COVID Misery
On Feb. 22, 2024, the University of California, San Francisco (UC, San Francisco) launched the world’s first tissue…
COVID-19 | Life Science History | Measles | Vaccine | WHO
WHO reported more than half the world faces high measles risk
On Feb. 21, 2024, the World Health Organization reported that more than half the world’s countries will be…
COVID-19 vaccination and boosting during pregnancy protects infants for six months
On Feb. 14, 2024, the National Institute of Allergy and Infectious Diseases (NIAID) reported study results that showed…
Switching arms improved effectiveness of two-dose vaccinations, Oregon Health & Science University study suggested
On Feb. 6, 2024, Oregon Health & Science University (OHSU) announced research that revealed as much as a…
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrated Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster
On Feb. 5, 2024, CSL and and Arcturus Therapeutics announced the results of a follow-up analysis of a…
Washington University’s Jeffrey T. Fort Neuroscience Research building dedicated
On Jan. 25, 2024, dozens of noted scientists, philanthropists, and Washington University, state and local leaders celebrated the…